InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Ramos-Blue™ Cells | TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for... | 2023 | Microb. Cell | Thierry S. et al. | DOI: 10.15698/mic2023.06.797 |
| QUANTI-Blue™ | TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for... | 2023 | Microb. Cell | Thierry S. et al. | DOI: 10.15698/mic2023.06.797 |
| A549-Dual™ Cells | TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for... | 2023 | Microb. Cell | Thierry S. et al. | DOI: 10.15698/mic2023.06.797 |
| ssRNA40/LyoVec™ | TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for... | 2023 | Microb. Cell | Thierry S. et al. | DOI: 10.15698/mic2023.06.797 |
| 2'3'-cGAMP | TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for... | 2023 | Microb. Cell | Thierry S. et al. | DOI: 10.15698/mic2023.06.797 |
| QUANTI-Luc™: Luciferase Detection Reagent | TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for... | 2023 | Microb. Cell | Thierry S. et al. | DOI: 10.15698/mic2023.06.797 |
| Poly(I:C) HMW | TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for... | 2023 | Microb. Cell | Thierry S. et al. | DOI: 10.15698/mic2023.06.797 |
| Poly(A:U) | TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for... | 2023 | Microb. Cell | Thierry S. et al. | DOI: 10.15698/mic2023.06.797 |
| 5'ppp-dsRNA | TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for... | 2023 | Microb. Cell | Thierry S. et al. | DOI: 10.15698/mic2023.06.797 |
| HEK-Blue™ Null1 Cells | TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for... | 2023 | Microb. Cell | Thierry S. et al. | DOI: 10.15698/mic2023.06.797 |
| Bafilomycin A1 | TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for... | 2023 | Microb. Cell | Thierry S. et al. | DOI: 10.15698/mic2023.06.797 |
| Ramos-Blue™ KD-MyD Cells | TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for... | 2023 | Microb. Cell | Thierry S. et al. | DOI: 10.15698/mic2023.06.797 |
| Double NF-κB–Readout HEK293 Reporter Cells | TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for... | 2023 | Microb. Cell | Thierry S. et al. | DOI: 10.15698/mic2023.06.797 |
| Poly(I:C) (HMW) / LyoVec™ | TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for... | 2023 | Microb. Cell | Thierry S. et al. | DOI: 10.15698/mic2023.06.797 |
| Human TLR3 Reporter HEK293 Cells (NF-κB and IL-8) | TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for... | 2023 | Microb. Cell | Thierry S. et al. | DOI: 10.15698/mic2023.06.797 |
| CRX-527 | A TLR4 agonist liposome formulation effectively stimulates innate immunity an... | 2023 | Innate Immun. | Hedges J.F. et al. | DOI: 10.1177/17534259231168725 |
| Primocin® | Microbiota-derived tryptophan catabolites mediate the chemopreventive effects... | 2023 | Nat Microbiol. | Han J.X. et al. | DOI: 10.1038/s41564-023-01363-5 |
| Anti-mouse Dectin-1 (CLEC7A) antibody | The Alzheimer's disease risk factor INPP5D restricts neuroprotective microgli... | 2023 | Alzheimers Dement. | Samuels J.D. et al. | DOI: 10.1002/alz.13089 |
| Plasmocin® - Mycoplasma Elimination Reagent | The potential effects of in vitro digestion on the physicochemical and biolog... | 2023 | Environ Pollut. | Vela L. et al. | DOI: 10.1016/j.envpol.2023.121656 |
| Normocin® - Antimicrobial Reagent | Constitutive secretion of pro-IL-18 allows keratinocytes to initiate inflamma... | 2023 | PLoS Pathog. | Johnson A.F. et al. | DOI: 10.1371/journal.ppat.1011321 |